BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3872746)

  • 1. Abnormal vitamin D metabolism in Paget's disease of bone.
    Guillard-Cumming DF; Beard DJ; Douglas DL; Johnson SK; Lawson-Matthew PJ; Russell RG; Kanis JA
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):559-66. PubMed ID: 3872746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D status in Paget's bone disease. Effects of calcitonin therapy.
    Nunziata V; Giannattasio R; di Giovanni G; Lettera AM; Nunziata CA
    Clin Orthop Relat Res; 1993 Aug; (293):366-71. PubMed ID: 8339504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decrease of the coefficient of intestinal calcium absorption with normal blood levels of 1,25-dihydroxyvitamin D and decreasing levels of 24,25-dihydroxyvitamin D in Paget's disease of bone].
    Traba ML; Climent P; Rapado A; de la Piedra C; Díaz Curiel M
    Rev Clin Esp; 1986 Nov; 179(8):401-3. PubMed ID: 3494277
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitamin D in Paget's disease of bone.
    Foldes J; Shamir S; Kidroni G; Menczel J
    Clin Orthop Relat Res; 1989 Jun; (243):275-9. PubMed ID: 2498022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
    Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
    J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone.
    Castro-Errecaborde N; de la Piedra C; Rapado A; Alvarez-Arroyo MV; Torres R; Traba ML
    J Clin Endocrinol Metab; 1991 Feb; 72(2):462-6. PubMed ID: 1991815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What do we know about the significance of vitamin D in Paget's disease of the bone?].
    Wilczek H; Stĕpán J; Justová V
    Cas Lek Cesk; 1995 Dec; 134(24):785-7. PubMed ID: 8599821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of intravenous and oral etidronate on vitamin D metabolism in man.
    Lawson-Matthew PJ; Guilland-Cumming DF; Yates AJ; Russell RG; Kanis JA
    Clin Sci (Lond); 1988 Jan; 74(1):101-6. PubMed ID: 3123117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell biology of Paget's disease.
    Reddy SV; Menaa C; Singer FR; Demulder A; Roodman GD
    J Bone Miner Res; 1999 Oct; 14 Suppl 2():3-8. PubMed ID: 10510206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D status in Crohn's disease: association with nutrition and disease activity.
    Harries AD; Brown R; Heatley RV; Williams LA; Woodhead S; Rhodes J
    Gut; 1985 Nov; 26(11):1197-203. PubMed ID: 3877663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and bone vitamin D metabolites in elective patients and patients after fracture.
    Alkalay D; Shany S; Dekel S
    J Bone Joint Surg Br; 1989 Jan; 71(1):85-7. PubMed ID: 2783695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extremely high circulating levels of 1 alpha,25-dihydroxyvitamin D3 in the marmoset, a new world monkey.
    Shinki T; Shiina Y; Takahashi N; Tanioka Y; Koizumi H; Suda T
    Biochem Biophys Res Commun; 1983 Jul; 114(2):452-7. PubMed ID: 6411087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
    Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
    J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of vitamin D on bone in vivo.
    Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H
    Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between bone apposition rate and vitamin D activity in phosphate-deficient rats.
    Harrison JE; Tam CS; Hitchman AJ; Hitchman A; Hasany SA; Jones G
    Metabolism; 1986 Feb; 35(2):126-9. PubMed ID: 3484801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D metabolism in pregnant rabbits: differences between the maternal and fetal response to administration of large amounts of vitamin D3.
    Kubota M; Ohno J; Shiina Y; Suda T
    Endocrinology; 1982 Jun; 110(6):1950-6. PubMed ID: 6280980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.